Trillium Therapeutics Appoints Dr. Ingmar Bruns as Chief Medical Officer

    NEXT STORY
    Immutep’s TACTI-002 Data to Be Presented at Society for Immunotherapy of Cancer 2020 Annual Meeting
    PREV STORY
    Ascendis Pharma A/S Announces Third Quarter 2020 Financial Results and Business Update Conference Call on November 11
    Subscribe to PM360
    Print Subscription
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Roche provides update on Phase III study of Tecentriq in women with advanced stage ovarian cancer

    author_avatar
    NASDAQ Market News

    RedHill Biopharma Receives Allowance for New U.S. Patent Covering RHB-106, an Encapsulated Bowel Preparation

    Once granted, the new formulation patent is expected to be valid until at least ...

    author_avatar
    NASDAQ Market News

    Reata Pharmaceuticals, Inc. Presents Interim Phase 1b Data for Omaveloxolone in the Treatment of Unresectable or Metastatic Melanoma

    IRVING, Texas, Dec. 11, 2017 (GLOBE NEWSWIRE) -- Reata Pharmaceuticals, Inc. (Nasdaq:RETA) (“Reata” or “the ...

    author_avatar
    NASDAQ Market News